Festoons and Malar Mounds

The tear trough, by contrast, is a depression rather than a fullness — it sits along the medial inferior orbital rim where the orbicularis-retaining ligament tethers the skin to bone. It is often treated with conservative tear trough correction or fat repositioning. Patients frequently have combinations of these findings, which is why an experienced oculoplastic evaluation is essential before any intervention.

What Type of Under-Eye Puffiness Do You Have?

This decision guide helps patients recognize which type of lower lid concern they likely have. It is not a substitute for an in-person evaluation, but it can help frame the conversation with Dr. Patel.

Causes and Risk Factors

Festoons and malar mounds develop because of a combination of intrinsic and extrinsic factors that weaken the lid-cheek soft tissue envelope and impair lymphatic drainage. Unlike pure orbital fat herniation, which is largely driven by septal weakening, festoons reflect a multifactorial process:

• Genetics: Many patients have parents or siblings with similar lid-cheek anatomy. Some ethnic groups show greater predisposition to malar mound formation.
• Chronic UV damage (solar elastosis): Years of sun exposure degrade dermal collagen and elastin, leaving lax, crepey skin that cannot resist gravitational descent.
• Lymphatic dysfunction: The lid-cheek junction is a watershed zone for lymphatic drainage. Once stasis develops, low-grade chronic edema deposits within the orbicularis and skin, perpetuating the bag.
• Orbicularis hypertrophy: Some patients have a thick, prominent orbicularis muscle that pre-disposes to redundant folds with age.
• Prior surgery: Lower blepharoplasty, midface lifting performed incorrectly, or excessive filler can paradoxically create or worsen festoons by disrupting lymphatic outflow.
• Allergies and rosacea: Patients with chronic allergic conjunctivitis or rosacea have ongoing inflammation that fuels lid-cheek edema.
• Smoking and alcohol: Both impair lymphatic function and accelerate dermal aging.

Why Fillers and Blepharoplasty Can Make Festoons Worse

This is perhaps the single most important section on this page. Patients regularly present to oculoplastic offices after having spent thousands of dollars on hyaluronic acid fillers or undergoing lower blepharoplasty — only to find their lid-cheek puffiness worse than before. Understanding why this happens is critical.

Hyaluronic acid fillers are hydrophilic — they bind water. When injected into a region already prone to lymphatic stasis, even small amounts of filler in the tear trough or malar region can amplify malar mound swelling for months or years. Filler placed too superficially over the malar eminence can persist for far longer than expected (some studies suggest 5–10 years), creating a chronic, fluctuating bag that looks worst in the morning and after sodium intake.

Standard lower blepharoplasty — particularly the transcutaneous skin-muscle flap approach — can disrupt the delicate lymphatic channels that cross the lid-cheek junction. In a patient with subclinical or mild malar mounds, this lymphatic insult can unmask or worsen a festoon that was previously invisible. This is why oculoplastic surgeons specifically warn patients with even subtle malar findings before recommending blepharoplasty.

Treatment Options

There is no single best treatment for festoons and malar mounds — the right approach depends on the severity, the dominant tissue component (skin vs. muscle vs. fluid), the patient’s skin type, and their tolerance for downtime. A modern oculoplastic approach often combines two or more modalities. The major categories of treatment include:

• Direct excision of the festoon or malar mound
• CO2 laser resurfacing for skin tightening and lymphatic remodeling
• Radiofrequency (RF) microneedling for moderate cases
• Midface lift (subperiosteal or SOOF lift) for malar descent
• Lymphatic management: compression, manual drainage, low-sodium diet
• Adjunctive treatments: doxycycline (off-label, anti-inflammatory effect, mainly when rosacea or inflammation contributes), topical retinoids, dissolution of prior filler

Direct Excision of Festoons

For severe, well-defined festoons — particularly in older patients with significant skin redundancy — direct excision remains the most definitive treatment. The procedure removes an ellipse of skin (and sometimes underlying orbicularis muscle) directly over the festoon itself. The trade-off is a visible scar along the cheek, which is why patient selection is critical.

Modern direct excision techniques carefully place the incision within an existing crease or wrinkle line, and the scar typically fades dramatically over 6–12 months. For patients with severe festoons and Fitzpatrick I–III skin, the resulting scar is often far less noticeable than the festoon it replaced. In darker skin types, scar visibility is a greater concern and laser or RF approaches are usually preferred.

CO2 Laser Resurfacing and RF Microneedling

For mild to moderate festoons — or in patients unwilling to accept a visible incision — energy-based skin tightening is the workhorse treatment. Fully-ablative CO2 laser resurfacing remains the gold standard for festoon improvement. It works through three mechanisms: immediate collagen contraction, neocollagenesis over 3–6 months, and improved lymphatic outflow as the inflammatory response remodels the dermal tissue.

CO2 resurfacing typically requires 7–14 days of social downtime, with prolonged erythema for 4–8 weeks. Two passes are often required, and many patients see significant improvement after a single treatment. Results continue to mature for up to a year. Learn more about energy treatments on our lasers page.

RF microneedling (devices such as Morpheus8, Vivace, or Sylfirm) is a less aggressive but effective alternative. It delivers radiofrequency energy via fine needles into the deep dermis and subcutaneous tissue, stimulating collagen contraction and dermal remodeling without ablating the epidermis. RF microneedling is typically performed as a series of 3–4 treatments spaced 4–6 weeks apart, with only 2–3 days of downtime per session. It is particularly useful in patients with darker skin types where CO2 carries higher pigmentation risk.

Midface Lift for Malar Mounds

When malar mounds are accompanied by descent of the midfacial soft tissues — visible flattening of the cheek, deepening of the nasolabial fold, and a tired, downturned appearance — a midface lift may be the most appropriate treatment. The procedure repositions the suborbicularis oculi fat (SOOF) and malar fat pad superiorly, restoring youthful cheek projection while simultaneously flattening the malar mound itself.

Midface lifting can be performed through a transconjunctival approach, a subciliary incision, or a temporal endoscopic approach — often combined with canthopexy to support the lower lid. When done correctly by an oculoplastic surgeon familiar with the anatomy of the lid-cheek junction, it produces some of the most natural and durable improvements available. When done incorrectly, however, it can cause lower lid retraction, ectropion, and worsened festooning — another reason specialist evaluation matters.

Candidacy and Consultation

An ideal candidate for festoon or malar mound treatment is a patient who:

• Has a clearly defined fold or pouch in the lid-cheek region that persists throughout the day
• Has realistic expectations — improvement is the goal, not perfection
• Understands that medical optimization (low sodium, antihistamines, smoking cessation) may be part of the plan
• Is willing to tolerate the downtime appropriate to the chosen modality
• Does not have active rosacea flares, untreated thyroid disease, or unmanaged allergic conditions driving the edema

The consultation should include careful inspection in both seated and supine positions, palpation to assess the pinchable skin component, evaluation for snap-back and lid distraction (to detect eyelid laxity), photographic documentation, and a discussion of prior filler or surgical history. In many cases, a trial of conservative measures — head-of-bed elevation, sodium restriction, topical retinoid — is recommended before committing to procedural intervention.

Recovery and Expected Outcomes

Recovery varies dramatically depending on the chosen treatment:

• Direct excision: 7–10 days of sutures, with visible incision pinkness for 2–4 months. Final scar maturation at 9–12 months.
• CO2 laser resurfacing: 7–14 days of social downtime, erythema for 4–8 weeks, continued improvement for 6–12 months.
• RF microneedling: 2–3 days of redness per session; series of 3–4 treatments over 3–4 months.
• Midface lift: 2–3 weeks of bruising and swelling, with final results at 3–6 months.

Patients should understand that festoon treatment is rarely “one and done.” The underlying lymphatic and dermal predisposition does not disappear, and maintenance treatments — touch-up laser, periodic RF, lifestyle measures — are often part of long-term care. With realistic expectations and a well-designed plan, however, most patients achieve dramatic and durable improvement in a concern they had been told was untreatable.

Finding an ASOPRS Specialist

Festoons and malar mounds are one of the clearest examples of a cosmetic concern that demands subspecialty expertise. The anatomy is subtle, the differential diagnosis is broad, and the risk of making the problem worse with the wrong intervention is real. ASOPRS-trained oculoplastic surgeons have completed approximately two years of fellowship training in ophthalmic plastic and reconstructive surgery of the eyelid, orbit, lacrimal system, and midface, and are uniquely positioned to evaluate and treat these conditions safely.

If you have been told that nothing can be done about your under-eye puffiness — or if you have already had filler or blepharoplasty that left you worse than before — you owe yourself a consultation with a true specialist.